Journal article
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
Abstract
BACKGROUND: Guidelines recommend long-term oral anticoagulation therapy for stroke prevention in patients with atrial fibrillation (AF). Treatment discontinuation rates in vitamin K antagonist (VKA)-treated patients are high but may be lower with non-VKA oral anticoagulant agents.
OBJECTIVES: The goal of this study was to describe and explore predictors of dabigatran etexilate persistence in patients with newly diagnosed AF over 2 years of …
Authors
Paquette M; França LR; Teutsch C; Diener H-C; Lu S; Dubner SJ; Sheng C; Rothman KJ; Zint K; Halperin JL
Journal
Journal of the American College of Cardiology, Vol. 70, No. 13, pp. 1573–1583
Publisher
Elsevier
Publication Date
September 2017
DOI
10.1016/j.jacc.2017.07.793
ISSN
0735-1097